2 completed, 1 unknown. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow Hepatomegaly: new trials by email Literature Review of Hepatomegaly trials Research Report on Hepatomegaly
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension of LOCKCYST Trial lanreotide - Polycystic Liver Disease, Hepatomegaly | Phase 2 / Phase 3 | Unknown | Radboud University Medical Center | 54 | 2008-04-01 | 2008-11-13 |
| Lanreotide as Treatment of Polycystic Livers Placebo, Lanreotide - Polycystic Liver Disease, Hepatomegaly | Phase 2 / Phase 3 | Completed | Radboud University Medical Center | 38 | 2007-10-01 | 2009-02-17 |
| Octreotide in Severe Polycystic Liver Disease Octreotide, Placebo - Polycystic Kidney, Autosomal Dominant, Polycystic Liver Disease | Phase 2 / Phase 3 | Completed | Mayo Clinic | 42 | 2007-01-01 | 2012-11-21 |
Liver Diseases (3) · Polycystic liver disease (3) · Polycystic Kidney Diseases (2) · Polycystic Kidney, Autosomal Dominant (2) · Abdominal Pain (1) · Multiple Pterygium Syndrome, Autosomal Dominant (1)
Abnormalities, Multiple (3) · Ciliopathies (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genetic Diseases, Inborn (3) · Hypertrophy (3) · Kidney Diseases (3) · Kidney Diseases, Cystic (3) · Male Urogenital Diseases (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3)
lanreotide (2) · Octreotide (1)
Radboud University Medical Center (2) · Mayo Clinic (1)
Belgium (2) · Netherlands (2) · United States (1)
Frederik Nevens, MD, PhD (2) · Loes van Keimpema, MSc (2) · Joost PH Drenth, MD, PhD (1) · Joost PH Drenth, PhD (1) · Marie C. Hogan, M.D., Ph.D. (1)
PMID 39356039, PMID 22773240, PMID 26166166
UL1RR024150 (1)